Silgan Holdings Inc. (NYSE:SLGN) Tightens Balance Sheet, Signals Near-Term Recovery Ahead

Silgan shows balance-sheet repair and steady cash returns while margins compress; near-term bias leans toward stabilization as leverage and cash-flow deficits remain the primary constraints.

Recent News

On March 20th reports indicated Silgan signalled interest in Germany’s Gerresheimer, initiating adviser-led outreach; on April 17th sources reported Gerresheimer rejected a takeover approach. On May 12th the board declared a quarterly cash dividend of $0.21 per share, payable June 15, 2026. The company’s proxy materials for the May 26, 2026 annual meeting outlined votes on director elections, an amendment to the 2004 Stock Incentive Plan and a say-on-pay advisory vote.

Technical Analysis

Directional strength (ADX 23.38) registers as an emerging trend, which supports the near-term stabilization narrative while signaling that momentum has room to develop further toward a clearer directional move.

Directional indicators show bullish pressure: DI+ registered a dip-and-reversal and DI- registered a peak-and-reversal, both patterns that align with increasing upside bias and support the introduction of buy-side pressure into short-term price action.

MACD stands slightly negative at -0.03 but the MACD line has turned increasing and sits above the signal line (-0.47), a classic bullish momentum signal that suggests negative momentum has begun to abate and short-term momentum now favors upside continuation.

MRO shows a dip-and-reversal at -16.78, indicating the price sits below target and the oscillator’s recent reversal implies potential mean reversion pressure toward the target level; that supports a constructive near-term outlook versus the current valuation headwinds.

RSI at 47.06 with a dip-and-reversal character indicates neutral-to-modestly constructive internals; momentum shows room to expand before reaching overbought territory and therefore can support a stabilization or recovery phase.

Price sits near short-term averages: the close at $40.91 trades above the 20-day average ($37.79) and near the 12/26-day EMAs (~$38.4), while remaining below the 200-day average ($41.20). That configuration implies near-term support from short-term averages but medium-term resistance near the longer-term mean, limiting the pace of any advance.

 


Fundamental Analysis

Profitability: EBIT stands at $125,578,000 and EBIT margin equals 8.04%, which trails the industry peer mean of 9.02% and median of 9.33%. QoQ EBIT margin improved by 16.80%, while YoY EBIT margin declined by 9.64%, signaling quarter-to-quarter recovery inside a year-over-year margin contraction.

Top-line and earnings: total revenue equals $1,561,258,000 with YoY revenue growth of 60.45%. Reported EPS of $0.78 beat the estimate of $0.74, producing an EPS surprise of 5.41% versus consensus. Forward EPS stands at $1.02 with a forward P/E near 42.10x, reflecting muted near-term earnings expansion priced into forward multiples.

Cash flow and liquidity: operating cash flow shows a seasonal outflow at $-799,573,000 and free cash flow totaled $-882,017,000, producing a free cash flow yield of -20.01%. The cash conversion cycle of 56.3 days sits near the high end of the industry peer range (industry peer high ~55.75 days), underscoring material working-capital absorption during the period. Current and quick ratios sit at 1.26 and 0.78 respectively, with the current ratio above the industry peer mean of 1.11, providing some near-term liquidity cushion despite negative operating cash flow.

Leverage and coverage: total debt equals $4,660,447,000 with net debt near $4,225,018,000. Debt-to-EBITDA registers at ~22.14x and debt-to-equity at ~2.01x, which sits above the industry peer mean of ~1.55x; interest coverage stands at 3.03x. Those metrics indicate elevated leverage and constrained interest-coverage capacity relative to typical peers.

Margins and returns: gross margin at 17.02% falls below the industry peer mean of 19.42%; operating margin sits at 8.69%, near the peer mean band but slightly lower than peer averages. Return on equity equals 2.72%, below the industry peer mean of 3.81%, reflecting modest capital returns amid elevated leverage.

Valuation: WMDST values the stock as over-valued. That conclusion ties directly to a negative free cash flow yield (-20.01%), large negative operating cash flow in the period, and elevated leverage (debt/EBITDA ~22.14x) that compresses the margin for error despite a P/E below the industry peer mean. Enterprise multiple near 41.01x sits slightly below the industry peer mean but does not offset cash-flow and leverage concerns identified above.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-03-31
REPORT DATE: 2026-04-29
NEXT REPORT DATE: 2026-07-29
CASH FLOW  Begin Period Cash Flow 1.1 B
 Operating Cash Flow -799.57 M
 Capital Expenditures -82.44 M
 Change In Working Capital -964.94 M
 Dividends Paid -22.85 M
 Cash Flow Delta -645.23 M
 End Period Cash Flow 435.4 M
 
INCOME STATEMENT REVENUE
 Total Revenue 1.6 B
 Forward Revenue 668.0 M
COSTS
 Cost Of Revenue 1.3 B
 Depreciation 84.9 M
 Depreciation and Amortization 84.9 M
 Research and Development
 Total Operating Expenses 1.4 B
PROFITABILITY
 Gross Profit 265.8 M
 EBITDA 210.5 M
 EBIT 125.6 M
 Operating Income 135.6 M
 Interest Income
 Interest Expense 41.4 M
 Net Interest Income -41.43 M
 Income Before Tax 84.1 M
 Tax Provision 22.3 M
 Tax Rate 26.5 %
 Net Income 63.0 M
 Net Income From Continuing Operations 63.0 M
EARNINGS
 EPS Estimate 0.74
 EPS Actual 0.78
 EPS Difference 0.04
 EPS Surprise 5.405 %
 Forward EPS 1.02
 
BALANCE SHEET ASSETS
 Total Assets 9.3 B
 Intangible Assets 3.3 B
 Net Tangible Assets -1.02 B
 Total Current Assets 3.0 B
 Cash and Short-Term Investments 435.4 M
 Cash 435.4 M
 Net Receivables 1.2 B
 Inventory 1.1 B
 Long-Term Investments 656.5 M
LIABILITIES
 Accounts Payable 817.0 M
 Short-Term Debt 988.3 M
 Total Current Liabilities 2.4 B
 Net Debt 4.2 B
 Total Debt 4.7 B
 Total Liabilities 7.0 B
EQUITY
 Total Equity 2.3 B
 Retained Earnings 3.6 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 21.96
 Shares Outstanding 105.680 M
 Revenue Per-Share 14.77
VALUATION
 Market Capitalization 4.4 B
 Enterprise Value 8.6 B
 Enterprise Multiple 41.008
Enterprise Multiple QoQ -2.772 %
Enterprise Multiple YoY -11.485 %
Enterprise Multiple IPRWA high: 54.307
median: 47.054
mean: 43.358
SLGN: 41.008
low: 35.912
 EV/R 5.529
CAPITAL STRUCTURE
 Asset To Equity 4.017
 Asset To Liability 1.331
 Debt To Capital 0.668
 Debt To Assets 0.5
Debt To Assets QoQ 8.077 %
Debt To Assets YoY -5.297 %
Debt To Assets IPRWA SLGN: 0.5
high: 0.452
mean: 0.401
median: 0.395
low: 0.216
 Debt To Equity 2.008
Debt To Equity QoQ 5.076 %
Debt To Equity YoY -9.605 %
Debt To Equity IPRWA high: 2.217
SLGN: 2.008
mean: 1.55
median: 1.394
low: 0.411
PRICE-BASED VALUATION
 Price To Book (P/B) 1.899
Price To Book QoQ -2.132 %
Price To Book YoY -27.384 %
Price To Book IPRWA high: 4.016
median: 2.896
mean: 2.883
SLGN: 1.899
low: 1.329
 Price To Earnings (P/E) 53.47
Price To Earnings QoQ -14.416 %
Price To Earnings YoY -13.911 %
Price To Earnings IPRWA high: 79.116
mean: 68.618
median: 67.197
SLGN: 53.47
low: 43.834
 PE/G Ratio 3.257
 Price To Sales (P/S) 2.823
Price To Sales QoQ -6.066 %
Price To Sales YoY -24.016 %
Price To Sales IPRWA high: 4.5
mean: 3.927
median: 3.645
low: 3.102
SLGN: 2.823
FORWARD MULTIPLES
Forward P/E 42.102
Forward PE/G 2.564
Forward P/S 6.598
EFFICIENCY OPERATIONAL
 Operating Leverage 3.831
ASSET & SALES
 Asset Turnover Ratio 0.167
Asset Turnover Ratio QoQ 7.308 %
Asset Turnover Ratio YoY -1.319 %
Asset Turnover Ratio IPRWA high: 0.228
mean: 0.194
median: 0.183
SLGN: 0.167
low: 0.151
 Receivables Turnover 1.786
Receivables Turnover Ratio QoQ 27.237 %
Receivables Turnover Ratio YoY -2.137 %
Receivables Turnover Ratio IPRWA high: 3.075
mean: 2.442
median: 2.343
SLGN: 1.786
low: 1.639
 Inventory Turnover 1.173
Inventory Turnover Ratio QoQ 1.411 %
Inventory Turnover Ratio YoY -2.764 %
Inventory Turnover Ratio IPRWA high: 2.396
mean: 1.529
median: 1.396
SLGN: 1.173
low: 1.139
 Days Sales Outstanding (DSO) 51.085
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 56.336
Cash Conversion Cycle Days QoQ -13.294 %
Cash Conversion Cycle Days YoY 1.977 %
Cash Conversion Cycle Days IPRWA SLGN: 56.336
high: 55.748
mean: -2.677
median: -7.339
low: -29.152
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 2.564
 CapEx To Revenue -0.053
 CapEx To Depreciation -0.971
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 6.0 B
 Net Invested Capital 7.0 B
 Invested Capital 7.0 B
 Net Tangible Assets -1.02 B
 Net Working Capital 609.0 M
LIQUIDITY
 Cash Ratio 0.185
 Current Ratio 1.258
Current Ratio QoQ 3.117 %
Current Ratio YoY 10.708 %
Current Ratio IPRWA high: 1.275
SLGN: 1.258
median: 1.119
mean: 1.113
low: 0.964
 Quick Ratio 0.78
Quick Ratio QoQ -0.023 %
Quick Ratio YoY 15.52 %
Quick Ratio IPRWA high: 0.998
SLGN: 0.78
median: 0.719
mean: 0.716
low: 0.536
COVERAGE & LEVERAGE
 Debt To EBITDA 22.139
 Cost Of Debt 0.812 %
 Interest Coverage Ratio 3.031
Interest Coverage Ratio QoQ 43.102 %
Interest Coverage Ratio YoY -0.331 %
Interest Coverage Ratio IPRWA high: 4.308
median: 3.835
mean: 3.816
SLGN: 3.031
low: 2.718
 Operating Cash Flow Ratio -0.384
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 77.632
DIVIDENDS
 Dividend Coverage Ratio 2.759
 Dividend Payout Ratio 0.362
 Dividend Rate 0.22
 Dividend Yield 0.005
PERFORMANCE GROWTH
 Asset Growth Rate -0.796 %
 Revenue Growth 6.309 %
Revenue Growth QoQ -123.463 %
Revenue Growth YoY 60.453 %
Revenue Growth IPRWA high: 7.841 %
median: 7.649 %
SLGN: 6.309 %
mean: 4.784 %
low: -5.177 %
 Earnings Growth 16.418 %
Earnings Growth QoQ -144.624 %
Earnings Growth YoY -565.231 %
Earnings Growth IPRWA high: 129.167 %
SLGN: 16.418 %
mean: 5.634 %
median: -10.345 %
low: -15.385 %
MARGINS
 Gross Margin 17.023 %
Gross Margin QoQ -1.058 %
Gross Margin YoY -7.669 %
Gross Margin IPRWA high: 23.024 %
median: 19.761 %
mean: 19.424 %
low: 17.93 %
SLGN: 17.023 %
 EBIT Margin 8.043 %
EBIT Margin QoQ 16.802 %
EBIT Margin YoY -9.639 %
EBIT Margin IPRWA high: 11.415 %
median: 9.326 %
mean: 9.019 %
SLGN: 8.043 %
low: 2.964 %
 Return On Sales (ROS) 8.688 %
Return On Sales QoQ -5.318 %
Return On Sales YoY -2.393 %
Return On Sales IPRWA high: 11.261 %
mean: 9.407 %
median: 9.353 %
SLGN: 8.688 %
low: 5.155 %
CASH FLOW
 Free Cash Flow (FCF) -882.02 M
 Free Cash Flow Yield -20.011 %
Free Cash Flow Yield QoQ -172.247 %
Free Cash Flow Yield YoY 42.295 %
Free Cash Flow Yield IPRWA high: 1.529 %
mean: -3.913 %
median: -5.785 %
low: -8.268 %
SLGN: -20.011 %
 Free Cash Growth -172.148 %
Free Cash Growth QoQ -146.681 %
Free Cash Growth YoY -8.719 %
Free Cash Growth IPRWA high: -155.294 %
SLGN: -172.148 %
mean: -186.664 %
median: -190.106 %
low: -233.429 %
 Free Cash To Net Income -13.992
 Cash Flow Margin -57.952 %
 Cash Flow To Earnings -14.353
VALUE & RETURNS
 Economic Value Added 0.02
 Return On Assets (ROA) 0.674 %
Return On Assets QoQ 249.223 %
Return On Assets YoY -13.921 %
Return On Assets IPRWA high: 1.225 %
median: 1.043 %
mean: 0.953 %
SLGN: 0.674 %
low: 0.227 %
 Return On Capital Employed (ROCE) 1.803 %
 Return On Equity (ROE) 0.027
Return On Equity QoQ 239.5 %
Return On Equity YoY -16.738 %
Return On Equity IPRWA high: 0.06
mean: 0.038
median: 0.037
SLGN: 0.027
low: 0.004
 DuPont ROE 2.744 %
 Return On Invested Capital (ROIC) 1.322 %
Return On Invested Capital QoQ 9.528 %
Return On Invested Capital YoY -10.856 %
Return On Invested Capital IPRWA high: 3.023 %
mean: 2.032 %
median: 1.904 %
SLGN: 1.322 %
low: 0.587 %

Six-Week Outlook

Near-term price bias appears modestly bullish: technical indicators (MACD crossing above its signal, DI patterns and a neutral RSI) support a stabilization and measured recovery scenario so long as short-term averages continue to hold as support. Primary risks through the next six weeks derive from continued negative operating cash flow, elevated leverage and any headline activity around M&A that could reprice risk rapidly. Traders should monitor short-term average support and the 200-day average as a medium-term resistance marker; deteriorating cash-flow headlines or renewed leverage pressure would reverse the constructive technical setup.

About Silgan Holdings Inc.

Silgan Holdings Inc. (NYSE:SLGN) manufactures and sells rigid packaging solutions for consumer goods worldwide. The company operates through three primary segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers. The Dispensing and Specialty Closures segment produces metal and plastic closures and dispensing systems for a variety of products, including food, beverages, healthcare, and personal care items. It also supplies capping/sealing equipment and detection systems. In the Metal Containers segment, Silgan manufactures steel and aluminum containers for food products such as pet food, vegetables, soups, and proteins, as well as general line metal containers for chemicals. The Custom Containers segment designs and produces custom and stock plastic containers for industries including personal care, healthcare, food and beverage, and household chemicals. Additionally, this segment offers thermoformed bowls and trays for food products and various plastic closures and fitments. Silgan markets its products primarily through a direct sales force, distributors, and an online shopping catalog. Founded in 1987, Silgan Holdings is headquartered in Stamford, Connecticut.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.